New registry aims to unlock secrets of rare dwarfism disorders

NCT ID NCT04569149

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a registry to collect health information from 200 people with rare forms of primordial dwarfism, such as MOPDII and Meier-Gorlin syndrome. Researchers hope to learn how these conditions change over a person's lifetime and improve future care. Participants provide data at enrollment and over time, with no experimental treatments involved.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOPDII are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

DNA ligase IV deficiency IMAGe syndrome Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, And Genital Anomalies Lowry-Wood syndrome Meier-Gorlin syndrome microcephalic osteodysplastic dysplasia, Saul-Wilson type microcephalic osteodysplastic primordial dwarfism microcephalic osteodysplastic primordial dwarfism type I microcephalic osteodysplastic primordial dwarfism type II RNU4ATAC spectrum disorder Roifman syndrome Seckel syndrome 1 Seckel syndrome 7

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nemours

    RECRUITING

    Wilmington, Delaware, 19803, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••